GHRS GH Research PLC

Sentiment & Price 1 ideas • 1 voices • 1 sources ▼
Sentiment Gauge
1
Bull
0
Bear
0
Watch
Bull 100% Bear 0%
Price & Sentiment
Loading chart...
Recent News Top Views ▼
No recent news for GHRS
No theses available
Feed
All Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
News✓
Loading...
All directions✓
▲ Long✓
▼ Short✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
18:16
Apr 18
u/amberlight3 Reddit r/wallstreetbets
GHRS's lead asset GH001 has exceptional Phase 2b data (4x effect size of standard of care) and holds FDA Breakthrough Therapy Designation. The EO's fast-track mechanism could grant GH001 a priority voucher, accelerating its Phase 3-to-approval path and validating its clinical advantage. Superior efficacy and short treatment duration give it a commercial moat; regulatory support de-risks the investment. Phase 3 trial failure, clinical hold re-emergence, competitor advancement.
GHRS
HIGH

About GHRS Analyst Coverage

Buzzberg tracks GHRS (GH Research PLC) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.